Europe: Financing rounds completed for HeartBeat.bio, Onward and Adcendo

There was a decidedly European flavour to healthcare financing rounds in a holiday-shortened week for some markets. Austria: HeartBeat.bio, a drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies, has established operations with seed financing of €1.5m (US$1.8m) from red-stars.com data. The company, a spin-off of…

You must be a HMI Subscriber to view this content.

Subscribe Now »